U.S. markets open in 5 hours 29 minutes

Mexco Energy Corporation (MXC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
18.15+0.78 (+4.49%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close17.37
Bid17.71 x 1200
Ask0.00 x 1800
Day's Range17.18 - 18.21
52 Week Range7.80 - 43.00
Avg. Volume30,746
Market Cap39.012M
Beta (5Y Monthly)1.21
PE Ratio (TTM)13.35
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
27% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MXC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Mexco Energy Corporation
    Analyst Report: EOG Resources, Inc.EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
  • GlobeNewswire


    MIDLAND, TX, June 27, 2022 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) reported results on its Annual Report, Form 10-K to the Securities and Exchange Commission for the fiscal year ended March 31, 2022. The Company reported net income of $2,855,066 or $1.36 per diluted share, for fiscal year 2022, compared to net income of $155,932, or $0.08 per diluted share, for fiscal 2021. Operating revenues in fiscal 2022 were $6,587,780, an increase of 135% when compared to fiscal 20

  • PR Newswire

    MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK

    MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in the production and development of phytomedicines, has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK.

  • GlobeNewswire

    Allied Corp Supports Veteran Focused National Organization “Tac-tical Games” as Platinum Sponsor

    KELOWNA, British Columbia., March 01, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce its support of the veterans organization Tactical Games. The Tactical Games organization provides multiple events across the US for veterans and athletes to sharpen their tactical skills while competing in multi-faceted events. Along with other National Sponsors, Allied has signed on as a platinum level sponsor to support the Tactical Games. Products from A